Neural vascular barrier maintains the optimal tissue microenvironment of central nervous system in which neural cells can function normally. In various neural diseases, the decrease in oxygen concentration, hypoxia, of affected tissues is known to accelerate the disease progression through disruption of neural vascular barrier. Therefore, the clarification of mechanisms underlying hypoxia-induced disruption of neural vascular barrier would definitely lead to the establishment of new effective therapies for intractable neural diseases. In the present study, we first found that hypoxia disrupts neural vascular barrier through pathways independent of HIF-1α and HIF-2α. Then, with a specific fluorescence probe for ferrous, Fe(II) ion, we have obtained the interesting data showing that hypoxia increased the intracellular level of Fe(II) ion in endothelial cells of our in vitro model for neural vascular barrier, and that hypoxia-induced disruption of neural vascular barrier could be inhibited by chelating Fe(II) ion in endothelial cells. Furthermore, in the presence of a reducing reagent for reactive oxygen species (ROS), hypoxia could not disrupt the neural vascular barrier despite that the hypoxic increase in intracellular level of Fe(II) ion was confirmed in endothelial cells. These results indicate that hypoxia-triggered increase in the level of intracellular Fe(II) ion and subsequent production of ROS, probably through Fenton reaction, are the essential pathway mediating the disruption of neural vascular barrier under hypoxia.
Introduction
For normal functioning of neural cells, the central nervous system (CNS) of multicellular organisms requires the tissue microenvironment kept in an optimal condition, and the homeostasis of neural tissue microenvironment is maintained by the function of neural vascular barrier including blood-brain barrier [1, 2] . Neural vascular barrier function is known to be attributable to capillary endothelial cells showing the neural tissue-specific differentiation to assembly a complex tight junction (TJ) network between the cells [3] . Therefore, the appropriate assembly of TJ between vascular endothelial cells is critical for the integrity of vascular barrier and consequently the maintenance of optimal tissue microenvironment in CNS [3, 4] . As the molecules involved in TJ assembly, claudins, occludin and junctional adhesion molecule (JAM) have been identified [5] . Accumulating evidence has indicated that claudins are integral membrane molecules regulating the function of the TJ as a barrier between blood and neural tissue parenchyma [6] . Claudins form a family which consists of 27 members with different expression patterns in tissues [7] . Among claudin family members, claudin-5 has been demonstrated to be the key member which determines the permeability of neural vascular endothelial cells [8] , although claudins-1, 3 and 12 are also reportedly to be expressed in the barrier-forming vascular endothelial cells [9, 10] .
Neural vascular barrier function is induced during the embryogenesis. However, the once established neural vascular barrier in adults is also under the dynamic control in response to various kinds of stress. In neural diseases, such as cerebral infarction, diabetic retinopathy and so forth, it is known that the decrease in oxygen concentration, hypoxia, of affected tissues give rise to the disruption of neural vascular barrier and consequently accelerates their disease progression [11] [12] [13] . Therefore, the analyses of mechanisms underlying hypoxia-induced disruption of neural vascular barrier would lead to the establishment of new therapies for intractable neural diseases. We have demonstrated that hypoxia disrupts neural vascular barrier through the disappearance of claudin-5 from cell membranes of barrier-forming endothelial cells [14] , and have further specified a disintegrin and metalloproteinases (ADAMs) 12 and 17 as the essential molecules for hypoxia-induced breakdown of neural vascular barrier [15] . However, no further details, for example, In organisms, iron is an abundant element with a vital physiological role in accepting and donating electrons. Inside the cells, iron exists mainly as ferrous, Fe(II), and ferric, Fe(III), ionic forms, and the chemical equilibrium between Fe(II)/Fe(III) is susceptible to the changes in oxygen concentration. Therefore, the intracellular free Fe(II) ion could increase and consequently gives rise to the oxidative stress for cells through production of hydroxyl radicals by Fenton reaction [16, 17] . This Fe(II) ion-mediated oxidative stress might be a candidate of mechanisms underlying the hypoxia-induced disruption of neural vascular barrier. Here, using specific fluorescence probe for Fe(II) ion, we demonstrate that tissue hypoxia disrupts the neural vascular barrier through the increase in intracellular level of Fe(II) ion.
Materials and methods

Cell culture
A mouse brain microvascular endothelial cell line, bEnd.3, was purchased from the American Type Culture Collection (Manassas, VA), and cultured in Dulbecco's Modified Eagle's medium with 4500 mg/l glucose (Sigma-Aldrich, St. Louis, MO) supplemented with 10% fetal bovine serum, at 37°C in a humidified incubator either with 5% CO 2 and 95% atmospheric air for normoxia or with 5% CO 2 and 1%O 2 balanced with N 2 for hypoxia for hypoxia. Oxygen-regulated Personal Multi Gas incubator (Astec Co., Ltd., Tokyo, Japan) was used to generate the hypoxic culture condition. In all the experiments, cells were cultured under normoxia in confluent state for 7-10 days before the start of experiments. To induce HIF-1α and HIF-2α in cultured cells, deferoxamine (DFO) was added to the culture medium (100 μM; solution in DMSO; Sigma-Aldrich, St. Louis, MO, USA). In order to chelate Fe(II) and reduce the reactive oxygen species (ROS), 2,2′-Bipyridyl (Bpy) (1 mM; solution in DMSO; Sigma-Aldrich, St. Louis, MO, USA) and N-acetyl-L-cysteine (NAC) (100 μM; solution in DMSO; SigmaAldrich, St. Louis, MO, USA) were added to culture medium, respectively, prior to the start of hypoxic incubation.
Immunofluorescence staining of cultured cells
bEnd.3 monolayers were fixed with 100% methanol at room temperature for 5 min, and were incubated with 10% Non-Immune Goat Serum (Invitrogen, Carlsbad, CA) for 30 min to block the nonspecific binding of antibodies. Then, the cell monolayers were reacted with rabbit polyclonal antibody against claudin-5 (1/25 dilution; Invitrogen), goat polyclonal antibody against hypoxia-inducible factor (HIF)-1α (1/500 dilution; NB100-479; Novus Biologicals, Littleton, CO, USA) or mouse monoclonal antibody against HIF-2α (1/50 dilution; sc-13596; Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 4°C overnight. After washing in PBS, the cell monolayers were incubated with Alexa Fluor 488 goat anti-rabbit IgG (1/200 dilution; Molecular Probes, Eugene, OR) for the staining of claudin-5 and HIF-1α, or Alexa Fluor 488 donkey anti-mouse IgG (1/200 dilution; Molecular Probes, Eugene, OR) for the staining of HIF-2α at room temperature under light protection for 1 h. NucBlue™ Fixed Cell ReadyProbes™ Reagent (R37606; Molecular Probes, Eugene, OR) was used to stain nuclei of cells. Stained cell monolayers were mounted in Fluorescence Mounting Medium (Dako Denmark A/S, Glostrup, Denmark), and observed under a Zeiss LSM5 Pascal laser confocal microscope and a Zeiss Axio Observer.Z1 fluorescence microscope (Carl Zeiss, Jena, Germany). For a quantitative analysis, the fluorescence intensities of claudin-5 on plasma membranes were measured using an operation menu installed in LSM5 Pascal [15, 18] . Three fields of a cell monolayer were randomly photographed, and 3 straight lines were drawn on each photograph. Then, fluorescence intensities at the points of cell membranes intersected with drawn straight lines were quantified. The mean value of fluorescence intensities of around 80 points was calculated as the level of claudin-5 on cell membrane for each monolayer. All experiments were performed independently in triplicate.
Transendothelial electrical resistance (TEER)
Electrical resistance across a bEnd.3 monolayer was measured as a functional index of vascular barrier. bEnd.3 cells were grown to confluent on fibronectin-coated inserts of 0.4 μm pore size, and the electrical resistance of the inserts was measured with the Millicell ERS Voltohmmeter (Millipore, Billerica, MA). TEERs of bEnd.3 monolayers were calculated by subtracting the resistance of blank inserts without cells, and multiplying the subtracted values by the surface areas of inserts. Each experiment was performed in triplicate.
Transfection of small interfering RNA (siRNA) and Real-Time Quantitative Polymerase Chain Reaction (Real-Time PCR)
Non-silencing siRNA for negative control and siRNAs specific for HIF-1α and HIF-2α as well as β-actin were purchased from Applied Biosystems (Applied Biosystems, Foster City, CA). Two different siRNAs were prepared for each target molecule, and their IDs are S67531 for HIF-1α siRNA#1, S67532 for HIF-1α siRNA#2 and S65525 for HIF-2α siRNA#1, S201294 for HIF-2α siRNA#2, respectively. For bEnd.3 cells in each well of 24-well plate, 50 μl of 0.24 μM siRNA solution diluted in Gibco Opti-MEM I (Life Technologies. Paisley, UK) was gently mixed with 50 μl of Gibco Opti-MEM I containing 1 μl of Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA). After further incubation at room temperature for 20 min, 100 μl of the reaction mixture was added to each well with 500 μl of culture medium (final concentration of siRNA; 20 nM). After 48 h, the cells were processed for experiments. Specific and significant silencing of target molecules was analyzed by Real-Time PCR according to the manufacture's instruction. Total RNA was isolated from bEnd.3 cells, reverse-transcribed and subjected to the Real-Time PCR reaction with the Eagle Taq Master Mix Kit (Roche Molecular Systems, Branchburg, NJ) and with TaqMan Gene Expression Assays (Applied Biosystems). IDs of TaqMan Gene Expression Assays used in this study are Mm00468869_m1 (Applied Biosystems, Foster City, CA) for HIF-1α and Mm01236112_m1 (Applied Biosystems, Foster City, CA) for HIF-2α. Reaction in 96-well plate was performed with StepOnePlus™ Real-Time PCR System (Applied Biosystems). The thermal cycle conditions were as follows; 2 min at 50°C and 10 min at 95°C, followed by 40 cycles at 95°C for 15 s and 60°C for 60 s. The comparative C T (ΔΔ C T ) method of relative quantification was used to determine the fold change in gene expression. With the comparative CT method, the StepOnePlus™ software measures amplification of the target as well as the endogenous control (β-actin) in a sample. RealTime PCR was repeated in triplicate for each sample.
Confocal fluorescence imaging experiments for ferrous iron
Confocal fluorescence imaging techniques were used for analysis of iron as previously described [19] . bEnd.3 cells grown on a dish were washed three times with PBS, and then the medium was replaced with fresh DMEM without phenol red containing 5 μM SiRhoNox-1, a specific fluorescent probe for Fe(II) ion dissolved in DMSO [19, 20] , in the presence or absence of 1 mM Bpy or 100 μM NAC. For hypoxic stimulation, cells were placed in Multi Gas incubator. After incubation of cells under hypoxia for 60 min, cells were washed with PBS on ice and then imaged. Image analysis was performed with Image J according to the previous report [19] .
Statistical analyses
Data were statistically analyzed with Student's t-test, since the variance was shown to be equal with F-test between the groups which D. Cui, et al. Experimental Cell Research 379 (2019) [166] [167] [168] [169] [170] [171] were to be compared in this study. Differences were considered to be statistically significant at P < 0.05. All data are presented as mean ± SD.
Results
DFO treatment cannot reproduce the hypoxia-induced disruption of neural vascular barrier
Confluent bEND.3 cells with barrier properties were treated with DFO, a chelating agent, which is often used as an alternative inducer of HIF-1α and HIF-2α to mimic hypoxic condition [21, 22] . Unexpectedly, in contrast to the significant disappearance of claudin-5 from cell membranes by hypoxic stimulus, no significant changes in the claudin-5 levels on cell membranes were observed in cells under normoxia with DFO treatment (Fig. 1A and B) . On the contrary, the decrease in claudin-5 levels on cell membranes by hypoxia was found to be inhibited in the presence of DFO (Fig. 1A and B) . Changes in the TEER of bEND.3 cell monolayer, an index of barrier function, correlated closely with the changes in the claudin-5 levels on cell membranes, indicating that DFO treatment cannot reproduce the hypoxia-induced disruption of neural vascular barrier. Since the nuclear accumulation of HIF-1α as well as HIF-2α, to the lesser extent as compared with HIF-1α, were confirmed to be induced in DFO-treated cells ( Fig. 2A) , it was hypothesized that the hypoxia-induced disappearance of claudin-5 from endothelial cell membranes and consequent disruption of neural vascular barrier is mediated by unknown mechanisms other than the pivotal pathway through HIF-1α or HIF-2α.
3.2.
Neither HIF-1α nor HIF-2α is involved in the hypoxia-induced disappearance of claudin-5 from endothelial cell membranes First, we investigated the levels of HIF-1α and HIF-2α in nuclei of cells under normoxia as well as those under hypoxia. Increase in the nuclear level of HIF-1α s well as HIF-2α was confirmed in bEND.3 cells under hypoxia for 1 h and 6 h, although the induction of HIF-2α was weak as compared with HIF-1α ( Fig. 2A) . To determine the roles of HIF-1α and HIF-2α in hypoxia-induced disappearance of claudin-5 from cell membranes, we investigated the changes in claudin-5 levels on cell membranes of bEND.3 cells in which the expression of HIF-1α or HIF-2α was suppressed by introducing the specific siRNAs for them (Fig. S1,  S2 ). It was shown that the suppression of either HIF-1α or HIF-2α has no effects on the hypoxia-induced disappearance of claudin-5 from cell membranes, indicating that HIF-1α as well as HIF-2α play no significant roles in hypoxia-induced disruption of neural vascular barrier ( Fig. 2B and C) .
Hypoxia increases the intracellular levels of Fe(II) ion in endothelial cells
Another possible mechanism by which the treatment with DFO leads to the inhibition of hypoxia-induced disappearance of claudin-5 from endothelial cell membranes was considered to be the suppression of Fenton reaction which requires Fe(II) ion [16] . Fenton reaction is a Fe(II) ion-catalyzed reaction to produce hydroxyl radicals, a kind of ROS having toxic effects on cells. Therefore, to discuss the involvement of Fenton reaction in the process of hypoxia-induced disruption of neural vascular barrier, the levels of Fe(II) ion in endothelial cells under normoxia or hypoxia were determined by an imaging experiment with the specific fluorescent probe for Fe(II) ion [19] . The result showed that the distinctly higher fluorescence signals for Fe(II) ion were observed in cells under hypoxic condition as compared with those under normoxic condition (Fig. 3A) , and the quantitative analyses indicated a 3.6-fold increase in intracellular signals under hypoxia for 60 min (Fig. 3B) . Those fluorescence signals were confirmed to correspond to Fe(II) ion since they were vanished in the presence of Bpy, a chelator specific for Fe(II) ion [19] . Another interesting finding was obtained by the experiment with NAC, an antioxidant which reduces ROS. Treatment of cells with NAC was shown to have no significant influence on the hypoxia-induced increase in intracellular Fe(II) ion levels, indicating that ROS are not involved upstream of hypoxic induction of Fe(II) ion (Fig. 3A and B) .
Hypoxia-induced disruption of neural vascular barrier depends on the increase in intracellular Fe(II) ion and subsequent production of ROS
We examined whether the increase in intracellular Fe(II) ion and subsequent production of ROS mediates the disruption of neural vascular barrier under hypoxia. It was shown that the levels of claudin-5 on cell membranes as well as the TEER of bEND.3 cell monolayers decrease are presented as mean ± SD from 3 independent experiments. Scale bars, 10 μm *P < 0.01; **P < 0.05; ns, not significant. significantly after exposure to hypoxia for 60 min, whereas those decreases are inhibited by chelating Fe(II) ion either by treatment with Bpy or by reducing ROS with NAC (Fig. 4) . These results indicate that the hypoxia-induced disruption of neural vascular barrier is mediated by the intracellular induction of Fe(II) ion and subsequent production of ROS through of Fenton reaction.
Discussion
Accumulative evidence has demonstrated that physiological as well as pathological phenomena triggered by tissue hypoxia are mediated mostly through the induction of HIF-1α and/or HIF-2α [23] [24] [25] [26] . Interestingly, in our present study, the hypoxia-induced disappearance of claudin-5 from bEND.3 cell membranes, a critical step for the disruption of neural vascular barrier, could not be reproduced by the treatment of endothelial cells with DFO which is often used as an alternative inducer of HIF-1α and HIF-2α. Suppression of either HIF-1α or HIF-2α expression with their specific siRNAs was found to have no significant influence on the hypoxia-induced disappearance of claudin-5 from cell membranes, demonstrating that HIF-1α and HIF-2α-dependent pathways are not involved in the hypoxia-induced disruption of neural vascular barrier. It was also noteworthy that DFO rather inhibited the hypoxic decrease in levels of cell membrane-localized claudin-5. Based on these findings, it can be concluded that hypoxia disrupts the neural vascular barrier through unknown mechanisms, other than HIF-1α and HIF-2α-dependent pathways, which must be suppressed in DFO-treated cells. Since DFO has a chelating activity for Fe(II) ion [27, 28] , the Fe(II) ion-dependent intracellular pathways were considered to be the candidates mediating the disruption of neural vascular barrier under hypoxia. This idea was supported by our present experiments with a Another interesting finding of our study is the inhibitory effect of NAC, a reducing agent for ROS [32] , on the disappearance of claudin-5 from cell membranes as well as the disruption of barrier function of bEND.3 cell monolayers under hypoxia. In addition, no significant suppression of the hypoxic increase in intracellular Fe(II) ion levels was obtained by NAC treatment, indicating that ROS is involved downstream of the hypoxia-induced of Fe(II) ion in bEND.3 cells. Taking these findings into consideration, the ROS production which is dependent on intracellular Fe(II) ion is essential for hypoxia-induced disappearance of claudin-5 from cell membranes and consequently the disruption of neural vascular barrier. The most probable candidate for ROS producing step downstream of Fe(II) ion is Fenton reaction which produces hydroxyl radicals. It is highly suggested that the hypoxia-induced disruption of neural vascular barrier is mediated by intracellular induction of Fe(II) ion and subsequent production of hydroxyl radicals which are the well-known ROS harmful for organisms [33, 34] . It is generally accepted that disruption of neural vascular barrier occurs in various intractable neural diseases and accelerates their disease progression [11, 13, 35] . Therefore, the procedure to repair the pathologically opened vascular barrier would lead to the establishment of new effective therapies for intractable neural diseases. Among pathological stimuli existing in tissues affected by neural diseases, hypoxia plays a pivotal role in the progression of diseases, and therefore we have focused our studies on the hypoxia-induced disruption of neural vascular barrier [36] [37] [38] . Although we have specified two cell membrane-localized molecules, ADAM12 and ADAM17, as essential molecules for the opening of neural vascular barrier under hypoxic condition [15] , no further detailed mechanisms remain unclarified. Elucidation of signaling pathways, both upstream and downstream of ADAM12 and ADAM17, is waited to have more candidates for therapeutic targets, in order to establish the effective therapies with a wide range of application as well as with few side effects. Our present study has demonstrated that the increase in intracellular Fe(II) ion level and subsequent production of ROS are essential for hypoxia-induced disruption of neural vascular barrier. These findings must be a clue to the responsible molecules available as therapeutic targets to establish the new effective therapies to eradicate the intractable neural diseases.
As another important aspect of our present data, it is noteworthy that endothelial cells have the sensing system for environmental oxygen concentration which is independent of HIF-1α and HIF-2α. Accumulative evidence has indicated that cells, in general, sense the changes in environmental oxygen concentration mainly by the hydroxyl state of proline residues of HIF-1α and/or HIF-2α which depends on the amount of oxygen molecules available for prolyl hydroxylases [23, 24] . Our present study has revealed that another sensing mechanism for oxygen concentration, independent of HIF-1α and HIF-2α, works in endothelial cells, and further studies with our present model of hypoxia-induced disruption of neural vascular barrier might figure out the new cellular oxygen sensors.
In conclusion, our present study demonstrated that neural vascular endothelial cells under hypoxia open the barrier, independently of HIF-1α and HIF-2α, by sensing the decrease in oxygen concentration through the induction of intracellular Fe(II) ion and subsequent production of ROS.
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